This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Authoring team

A swelling (fluid filled sac) can be palpated over the olecranon process (1)

  • onset of symptoms can be from several hours to several days (2)
  • the swelling is usually movable (3) and there can be localised tenderness (4)
  • movement of the elbow joint does not cause pain except at extreme flexion where compression of the swollen bursal compartment may induce pain (3)

Septic and non-septic bursitis cannot always be differentiated from the clinical features (4)

  • a painless, non tender, simple swollen bursa that has been present for days to weeks is almost always due to non septic causes (2,5)
  • the following features may suggest a septic olecranon bursitis:
    • hot, tender, painful, and red swelling of the bursa
    • systemic symptoms like fever and rigors
    • immunocompromised state (4)
    • abrasion or laceration over the bursa (3)
    • seeking medical help early in the disease (2)
  • erythema (in 63-100% of septic cases vs 25% of non-septic cases) and peribursal cellulites (more than 60% of septic cases and 25% of noninfective cases) is seen in both types (2,4)

Clinical differentiation of acute gouty olecranon bursitis from septic olecranon bursitis is complicated since both present with red, hot, swollen and tender bursae with associated fever and raised white cell count (5).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.